ofloxacin has been researched along with nitrofurantoin in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 2 (7.69) | 18.2507 |
| 2000's | 13 (50.00) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 2 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Blango, MG; Mulvey, MA | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Ludwig, G; Pauthner, H | 1 |
| Hooton, TM; Stamm, WE; Tiu, F; Winter, C | 1 |
| Liudvig, G | 1 |
| Boukadida, J; Boukadida, N; Elraii, S | 1 |
| Chen, J; Ge, JH; Mai, ED; Su, QZ; Zhang, QM | 1 |
| Chinitz, DP; Kahan, E; Kahan, NR | 2 |
| De Neeling, AJ; Geerlings, SE; Hoepelman, AI; Meiland, R | 1 |
| Lajiness, MJ | 1 |
| Chintz, DP; Kahan, E; Kahan, NR; Kitai, E; Waitman, DA | 1 |
| Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
| Alarfaj, AA; Hirad, AH; Kosanam, S; Ponsudha, P; Prasada Rao, CMM; Selvam, N; Sundaram, SR; Surendhar, PA; Suriyakrishnaan, K; Vennila, T | 1 |
| Alfandari, S; Bajolet, O; Blanchard, H; Colomb-Cotinat, M; Daniau, C; Dumartin, C; Lecuru, M; Simon, L | 1 |
1 review(s) available for ofloxacin and nitrofurantoin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for ofloxacin and nitrofurantoin
| Article | Year |
|---|---|
Clinical experience with ofloxacin in upper and lower urinary tract infections. A comparison with co-trimoxazole and nitrofurantoin.
Topics: Anti-Infective Agents; Drug Combinations; Female; Humans; Male; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Oxazines; Respiratory Tract Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women.
Topics: Acute Disease; Adult; Amoxicillin; Anti-Infective Agents; Cefadroxil; Confidence Intervals; Costs and Cost Analysis; Cystitis; Drug Administration Schedule; Female; Humans; Nitrofurantoin; Ofloxacin; Prospective Studies; Rectum; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urethra; Vagina | 1995 |
[Clinical experience with the use of ofloxacin in infections of the upper and lower urinary tracts: demonstrations of the results of clinical trials].
Topics: Anti-Infective Agents, Urinary; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Nitrofurantoin; Ofloxacin; Recurrence; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 1996 |
The tools of an evidence-based culture: implementing clinical-practice guidelines in an Israeli HMO.
Topics: Adult; Anti-Bacterial Agents; Clinical Competence; Cystitis; Evidence-Based Medicine; Female; Focus Groups; Guideline Adherence; Health Maintenance Organizations; Humans; Inservice Training; Israel; Medical Staff; Nitrofurantoin; Ofloxacin; Organizational Case Studies; Practice Guidelines as Topic; Practice Patterns, Physicians' | 2009 |
21 other study(ies) available for ofloxacin and nitrofurantoin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Persistence of uropathogenic Escherichia coli in the face of multiple antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Cell Membrane Permeability; Cells, Cultured; Drug Resistance, Bacterial; Endosomes; Escherichia coli; Escherichia coli Infections; Female; Humans; Mice; Mice, Inbred CBA; Microbial Sensitivity Tests; Recurrence; Urinary Bladder; Urinary Tract Infections; Urothelium | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Profile and sensitivity to antibiotics of 2063 uropathogenic bacteria isolated in the center of Tunisia].
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteria; Colistin; Escherichia coli; Female; Gentamicins; Hospitals, University; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Tunisia; Urinary Tract Infections; Urine | 2002 |
[Continuous in situ monitoring of the dissolution rate of solid pharmaceutical preparations using a multiple channel fiber-optic chemical sensor].
Topics: Chemistry, Pharmaceutical; Fiber Optic Technology; Metronidazole; Nitrofurantoin; Ofloxacin; Optical Fibers; Solubility; Tablets; Transducers | 2003 |
Longer than recommended empiric antibiotic treatment of urinary tract infection in women: an avoidable waste of money.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Drug Administration Schedule; Drug Costs; Drug Utilization; Female; Guideline Adherence; Humans; Israel; Middle Aged; Nitrofurantoin; Ofloxacin; Practice Patterns, Physicians'; Urinary Tract Infections | 2004 |
Physician adherence to recommendations for duration of empiric antibiotic treatment for uncomplicated urinary tract infection in women: a national drug utilization analysis.
Topics: Adolescent; Adult; Aged; Drug Utilization; Female; Humans; Middle Aged; Nitrofurantoin; Ofloxacin; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2004 |
Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuria.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Bacteriuria; Ciprofloxacin; Diabetes Complications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Middle Aged; Nitrofurantoin; Norfloxacin; Ofloxacin; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination | 2004 |
Common antibiotics for the treatment of urinary tract infections.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Costs; Humans; Nitrofurantoin; Nurse's Role; Ofloxacin; Patient Education as Topic; Patient Selection; Sulfamethoxazole; Urinary Tract Infections | 2008 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
Assessment of Bacterial Isolates from the Urine Specimens of Urinary Tract Infected Patient.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Urinary Tract; Urinary Tract Infections | 2022 |
Evolution of antibiotic treatments for healthcare-associated infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in France.
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Clavulanic Acid; Cross Infection; Delivery of Health Care; Enterobacteriaceae; Enterobacteriaceae Infections; France; Humans; Nitrofurantoin; Ofloxacin; Penicillins; Urinary Tract Infections | 2022 |